Preliminary Results of a Phase I/II Study of Simultaneous Boost Irradiation Radiotherapy for Locally Advanced Nasopharyngeal Carcinoma |
Xiang, Li
(State Key Laboratory of Oncology in South China, Department of Radiation Therapy, Cancer Centre, Sun Yat-Sen University)
Wang, Yan (State Key Laboratory of Oncology in South China, Department of Radiation Therapy, Cancer Centre, Sun Yat-Sen University) Xu, Bing-Qing (State Key Laboratory of Oncology in South China, Department of Radiation Therapy, Cancer Centre, Sun Yat-Sen University) Wu, Jing-Bo (Department of Oncology, Affiliated Hospital of Luzhou Medical College) Xia, Yun-Fei (State Key Laboratory of Oncology in South China, Department of Radiation Therapy, Cancer Centre, Sun Yat-Sen University) |
1 | Yu KH, Leung SF, Tung SY (2005). Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Head Neck, 27, 397-405. DOI ScienceOn |
2 | Aaronson NK, Ahmedzai S, Bergman B, et al (1993). The European Organization for Research and Treatment of Cancer QLQ-C30, a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 85, 365-76. DOI ScienceOn |
3 | Chau RM, Teo PM, Choi PH (2001). Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma. Radiother Oncol, 58, 143-53. DOI ScienceOn |
4 | Chau RM, Teo PM, Kam MK (2007). Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord. Med Dosim, 32, 263-70. DOI ScienceOn |
5 | Chen HH; Tsai ST; Wang MS (2006). Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 66, 1408-14. DOI ScienceOn |
6 | Cmelak AJ, Cox RS, Adler JR (1997). Radiosurgery for skull base malignancies and nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 37, 997-1003. DOI ScienceOn |
7 | Cox JD, Stetz J, Pajak TF (1995). Toxicity criteria of theRadiation Therapy Oncology Group (RTOG) and theEuropean Organization for Research and Treatment ofCancer (EORTC). Int J Radiat Oncol Biol Phys, 13, 1341-6. |
8 | Cuihttp: //item.taobao.com/item.htm?spm=a1z10.5.w4002-1294787290.52.pXxH6m&id=35391177527 NJ; |
9 | Zhao CH; Hu YH, et al (1992). Influence factors of local recurrences of nasopharyngeal carcinoma (NPC)and the results of re-irradiation-an analysis of 214 patients. Chinese journal of cancer, 11, 375-79. |
10 | Dimery IW, Peters LJ, Goepfert H, et al (1993). Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol, 11, 1919 -28. DOI |
11 | Fleming ID, Cooper JS, Henson DE (2002). American Joint Committee on Cancer: AJCC Cancer Staging Manual. New York, NY: Springer-Verlag. |
12 | Graff P, Lapeyre M, Desandes E (2007). Impact of intensitymodulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys, 67, 1309-17. DOI ScienceOn |
13 | Hara W, Loo BW Jr (2008). Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 71, 393-400. DOI ScienceOn |
14 | Kam MK, Teo PM, Chau RM, et al (2004). Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy, the Hong Kong experience [J]. Int J Radiat Oncol Biol Phys, 60, 1440-50. DOI ScienceOn |
15 | Huang XB, Xia YF, He ZC, et al (2008). Three-Dimensional dosimetric evaluation of split-filling and simultaneous boost irradiation in radiotherapy for local advanced nasopharyngeal carcinoma. J Sun Yat-Sen Univ, 29, 303-11. |
16 | Johnson FM, Garden AS, Palmer JL (2005). A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 63, 717-24. DOI ScienceOn |
17 | Kam MK, Chau RM, Suen J, et al (2003). Intensity-modulated radiotherapy in nasopharyngeal carcinoma, dosimetric advantage over conventional plans and feasibility of dose escalation [J]. Int J Radiat Oncol Biol Phys, 56, 145-57. DOI ScienceOn |
18 | Kaplan EL, Meier P (1958). Nonparametric estimation from incomplete observation. J Am Stat Assoc, 53, 457-81. DOI ScienceOn |
19 | Kim K; Wu HG, Kim HJ (2009). Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Head Neck, 31, 1121-8. DOI ScienceOn |
20 | Kwong DL, Sham JS, Chua DT (1997). The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 39, 703-10. DOI ScienceOn |
21 | Kwong DL, Sham JS, Leung LH (2006). Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 64, 374-81. DOI ScienceOn |
22 | Lee AW; Sze WM; Yau TK (2001). Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity. Radiother Oncol, 58, 121-30. DOI ScienceOn |
23 | Lai SZ, Li WF, Chen L (2010). How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients? Int J Radiat Oncol Biol Phys, 1-8. |
24 | Le QT, Tate D, Koong A (2003). Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 56, 1046-54. DOI ScienceOn |
25 | Lee AW, Sze WM, Au JS (2005). Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience.Int J Radiat Oncol Biol Phys, 61, 1107-16. DOI ScienceOn |
26 | Lee N, Xia P, Quivey JM, et al (2002). Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma, an update of the UCSF experience [J]. Int J Radiat Oncol Biol Phys, 53, 12-22. DOI ScienceOn |
27 | Li ZQ, Xia YF, Liu Q (2006). Radiotherapy-related typing in 842 patients in canton with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 66, 1011-6. DOI ScienceOn |
28 | Lin S, Pan J, Han L (2009). Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys, 75, 1071-8. DOI ScienceOn |
29 | Lu H, Yao M (2008). The current status of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma.Cancer Treat Rev, 34, 27-36. |
30 | Lu H, Peng L, Yuan X, et al (2009). Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia. Cancer Treat Rev, 35, 345-53. DOI ScienceOn |
31 | Lu TX, Mai WY, Bin ST, et a1 (2001). Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy [J]. Int J Radiat Oncol Biol Phys, 51, 589-98. DOI ScienceOn |
32 | Rades D; Fehlauer F; Wroblesky J (2007). Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy. Oral Oncol, 43, 535-43. DOI ScienceOn |
33 | Sobin LH, Wittekind CH (2002). International Union Against Cancer (UICC): TNM Classification of Malignant Tumors. New York, NY: Wiley-Liss. |
34 | Teo PM, Leung SF, Chan AT (2000). Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys, 48, 1311-22. DOI ScienceOn |
35 | Teo PM, Leung SF, Tung SY (2006). Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG). Radiother Oncol, 79, 27-33. DOI ScienceOn |
36 | Wolden SL, Chen WC, Pfister DG (2006). Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys, 64, 57-62. DOI ScienceOn |
37 | Xiao WW, Huang SM, Han F (2010). Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: longterm results of a phase 2 study. Cancer, 117, 1874-83. |
38 | Wolden SL; Zelefsky MJ; Kraus DH (2001). Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol, 19, 1105-10. DOI |
39 | Wong FC, Ng AW, Lee VH (2010). Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 76, 138-45. DOI ScienceOn |
40 | Wu HB, Wang QS, Wang MF (2011). Preliminary study of 11C-choline PET/CT for T staging of locally advanced nasopharyngeal carcinoma: comparison with 18F-FDG PET/CT. J Nucl Med, 52, 342-6. |
41 | Xie GF, Cao KJ, Li Y (2005). Impact of dose boost in skull base on recurrence of stage T4 nasopharyngeal carcinoma. Chin J Cancer, 24, 1246-8. |
42 | Yeh SA; Tang Y; Lui CC (2005). Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys, 62, 672-9. DOI ScienceOn |
43 | Yin WB, Yu ZH, Xu GZ (2008). Radiation Oncology. Peking Union Medical College Press, BeiJing, 458. |